APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treatment for Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Treatment for Mental Health Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchTreatment for Mental Health Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment for Mental Health Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Treatment for Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment for Mental Health Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment for Mental Health Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Treatment for Mental Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Treatment for Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Treatment for Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Treatment for Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Treatment for Mental Health market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Treatment for Mental Health market include Takeda, Johnson & Johnson, Eli Lilly, Pfizer and Shionogi, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Treatment for Mental Health market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Treatment for Mental Health and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Treatment for Mental Health revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Treatment for Mental Health market.

Treatment for Mental Health Segment by Company

Takeda

Johnson & Johnson

Eli Lilly

Pfizer

Shionogi

Treatment for Mental Health Segment by Type

Teenager

Adult

Treatment for Mental Health Segment by Application

Hospital

Clinic

Others

Treatment for Mental Health Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Treatment for Mental Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Treatment for Mental Health key companies, revenue, market share, and recent developments.

3. To split the Treatment for Mental Health breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Treatment for Mental Health market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Treatment for Mental Health significant trends, drivers, influence factors in global and regions.

6. To analyze Treatment for Mental Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment for Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment for Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment for Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Treatment for Mental Health industry.

Chapter 3: Detailed analysis of Treatment for Mental Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Treatment for Mental Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Treatment for Mental Health in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Treatment for Mental Health Industry Trends Table 2. Treatment for Mental Health Industry Drivers Table 3. Treatment for Mental Health Industry Opportunities and Challenges Table 4. Treatment for Mental Health Industry Restraints Table 5. Global Treatment for Mental Health Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Treatment for Mental Health Revenue Share by Company (2021-2026) Table 7. Global Treatment for Mental Health Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Treatment for Mental Health Key Company Manufacturing Base & Headquarters Table 9. Global Treatment for Mental Health Company, Product Type & Application Table 10. Global Treatment for Mental Health Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Treatment for Mental Health by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Teenager Table 15. Significant Companies of Adult Table 16. Global Treatment for Mental Health Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Treatment for Mental Health Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Treatment for Mental Health Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Treatment for Mental Health Sales Value Share by Type (2021-2026) Table 20. Global Treatment for Mental Health Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Others Table 24. Global Treatment for Mental Health Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Treatment for Mental Health Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Treatment for Mental Health Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Treatment for Mental Health Sales Value Share by Application (2021-2026) Table 28. Global Treatment for Mental Health Sales Value Share by Application (2027-2032) Table 29. Global Treatment for Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Treatment for Mental Health Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Treatment for Mental Health Sales Value Share by Region (2021-2026) Table 32. Global Treatment for Mental Health Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Treatment for Mental Health Sales Value Share by Region (2027-2032) Table 34. Global Treatment for Mental Health Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Treatment for Mental Health Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Treatment for Mental Health Sales Value Market Share by Country (2021-2026) Table 37. Global Treatment for Mental Health Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Treatment for Mental Health Sales Value Market Share by Country (2027-2032) Table 39. Takeda Company Information Table 40. Takeda Business Overview Table 41. Takeda Treatment for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Takeda Treatment for Mental Health Product Portfolio Table 43. Takeda Recent Development Table 44. Johnson & Johnson Company Information Table 45. Johnson & Johnson Business Overview Table 46. Johnson & Johnson Treatment for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Johnson & Johnson Treatment for Mental Health Product Portfolio Table 48. Johnson & Johnson Recent Development Table 49. Eli Lilly Company Information Table 50. Eli Lilly Business Overview Table 51. Eli Lilly Treatment for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Eli Lilly Treatment for Mental Health Product Portfolio Table 53. Eli Lilly Recent Development Table 54. Pfizer Company Information Table 55. Pfizer Business Overview Table 56. Pfizer Treatment for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Pfizer Treatment for Mental Health Product Portfolio Table 58. Pfizer Recent Development Table 59. Shionogi Company Information Table 60. Shionogi Business Overview Table 61. Shionogi Treatment for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Shionogi Treatment for Mental Health Product Portfolio Table 63. Shionogi Recent Development Table 64. Research Programs/Design for This Report Table 65. Authors List of This Report Table 66. Secondary Sources Table 67. Primary Sources List of Figures Figure 1. Treatment for Mental Health Product Image Figure 2. Global Treatment for Mental Health Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment for Mental Health Market Size (2021-2032) & (US$ Million) Figure 4. Global Treatment for Mental Health Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Teenager Image Figure 8. Adult Image Figure 9. Global Treatment for Mental Health Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Treatment for Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Treatment for Mental Health Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Treatment for Mental Health Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Treatment for Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Treatment for Mental Health Sales Value Share by Application (2021-2032) Figure 18. Global Treatment for Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Treatment for Mental Health Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Treatment for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 21. North America Treatment for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Treatment for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Treatment for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Treatment for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Treatment for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Treatment for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 27. South America Treatment for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Treatment for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Treatment for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Treatment for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Teenager
  • Adult
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Takeda
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • Shionogi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Treatment for Mental Health Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Treatment for Mental Health Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Treatment for Mental Health Market Dynamics
  1. 2.1 Treatment for Mental Health Industry Trends
  2. 2.2 Treatment for Mental Health Industry Drivers
  3. 2.3 Treatment for Mental Health Industry Opportunities and Challenges
  4. 2.4 Treatment for Mental Health Industry Restraints
3 Treatment for Mental Health Market by Company
  1. 3.1 Global Treatment for Mental Health Company Revenue Ranking in 2025
  2. 3.2 Global Treatment for Mental Health Revenue by Company (2021-2026)
  3. 3.3 Global Treatment for Mental Health Company Ranking (2024-2026)
  4. 3.4 Global Treatment for Mental Health Company Manufacturing Base and Headquarters
  5. 3.5 Global Treatment for Mental Health Company Product Type and Application
  6. 3.6 Global Treatment for Mental Health Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Treatment for Mental Health Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Treatment for Mental Health Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Treatment for Mental Health Market by Type
  1. 4.1 Treatment for Mental Health Type Introduction
  2. 4.1.1 Teenager
  3. 4.1.2 Adult
  4. 4.2 Global Treatment for Mental Health Sales Value by Type
  5. 4.2.1 Global Treatment for Mental Health Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Treatment for Mental Health Sales Value by Type (2021-2032)
  7. 4.2.3 Global Treatment for Mental Health Sales Value Share by Type (2021-2032)
5 Treatment for Mental Health Market by Application
  1. 5.1 Treatment for Mental Health Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Treatment for Mental Health Sales Value by Application
  6. 5.2.1 Global Treatment for Mental Health Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Treatment for Mental Health Sales Value by Application (2021-2032)
  8. 5.2.3 Global Treatment for Mental Health Sales Value Share by Application (2021-2032)
6 Treatment for Mental Health Regional Value Analysis
  1. 6.1 Global Treatment for Mental Health Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Treatment for Mental Health Sales Value by Region (2021-2032)
  3. 6.2.1 Global Treatment for Mental Health Sales Value by Region: 2021-2026
  4. 6.2.2 Global Treatment for Mental Health Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Treatment for Mental Health Sales Value (2021-2032)
  7. 6.3.2 North America Treatment for Mental Health Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Treatment for Mental Health Sales Value (2021-2032)
  10. 6.4.2 Europe Treatment for Mental Health Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Treatment for Mental Health Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Treatment for Mental Health Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Treatment for Mental Health Sales Value (2021-2032)
  16. 6.6.2 South America Treatment for Mental Health Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Treatment for Mental Health Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Treatment for Mental Health Sales Value Share by Country, 2025 VS 2032
7 Treatment for Mental Health Country-level Value Analysis
  1. 7.1 Global Treatment for Mental Health Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Treatment for Mental Health Sales Value by Country (2021-2032)
  3. 7.2.1 Global Treatment for Mental Health Sales Value by Country (2021-2026)
  4. 7.2.2 Global Treatment for Mental Health Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Treatment for Mental Health Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Treatment for Mental Health Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Treatment for Mental Health Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Treatment for Mental Health Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Treatment for Mental Health Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Treatment for Mental Health Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Treatment for Mental Health Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Shionogi
  26. 8.5.1 Shionogi Company Information
  27. 8.5.2 Shionogi Business Overview
  28. 8.5.3 Shionogi Treatment for Mental Health Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shionogi Treatment for Mental Health Product Portfolio
  30. 8.5.5 Shionogi Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst